Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Ethical issues with xenotransplantation clinical trials

- Featured Image

Xenotransplantation is the transplantation of living cells, tissues or organs from one species to another, such as from animals to humans. This includes transplanting human material that has been exposed to animal material while outside the human body.

Some animal materials are already used in humans, such as pig heart valves, but these are treated so that they contain no living cells. In contrast, xenotransplants comprise living cells that perform the same functions as the organ, tissue or cells they are intended to replace.

Progress in international research has raised interest in investigating xenotransplantation as an alternative to the clinical use of human material.

While whole organ xenotransplantation remains a distant possibility until research overcomes immunological hurdles, there has been much progress in cellular xenotransplantation. The immunological, microbiological and physiological barriers to xenotransplantation are being investigated in pre-clinical and clinical trials internationally. Ultimately, these could be tested in Australian clinical trials.

Australia has a robust framework for the conduct of clinical trials, yet there is limited guidance on the ethical review and conduct of xenotransplantation trials.

Such trials pose unique challenges due to the potential for transmitting infectious and untreatable diseases from animals to humans. This poses a risk not…

email